US Protects Medical Marijuana
Post# of 266
(Total Views: 385)
Posted On: 03/23/2018 7:19:04 AM
New Federal Spending Bill Includes Medical Marijuana Protections
by Justin Strekal, NORML Political Director
March 21, 2018
Comments
Marijuana medicineUpdate: The omnibus passed the House of Representatives on Thursday.
As part of the newly proposed appropriations package known as an omnibus bill, a spending restriction upon the Department of Justice from prosecuting state-legal medical marijuana programs will remain in place through the end of September.
Known as the Rohrabacher-Blumenauer amendment, it explicitly states that federal funds cannot be used to prevent states from “implementing their own state laws that authorize the use, distribution, possession or cultivation of medical marijuana.”
The amendment has been in place since 2014, as part of annual spending bills. Because the provision was initially approved as a budgetary amendment, it must be explicitly re-authorized by Congress as part of either a continuing resolution or a new fiscal year appropriations bill in order to maintain in effect.
Attorney General Jeff Sessions wants nothing more than to see these protections go away. In a letter he sent to Congressional leadership last year, he wrote: “I believe it would be unwise for Congress to restrict the discretion of the Department to fund particular prosecutions, particularly in the midst of a historic drug epidemic and potentially long-term uptick in violent crime.”
In the past month, NORML has worked with Representatives Rohrabacher and Blumenauer in recruiting 60 additional members of Congress to co-sign a letter of their own to Congressional leadership, which states, “We respectfully request that you include language barring the Department of Justice from prosecuting those who comply with their state’s medical marijuana laws. We believe such a policy is not only consistent with the wishes of a bipartisan majority of the members of the House, but also with the wishes of the American people.”
Last year, the language was initially included as part of a Senate appropriations bill thanks to Senator Patrick Leahy (D-VT) yet was absent from the House’s funding proposal because House Rules Committee Chair Peter Sessions (R-TX) refused to allow House members to vote on it. As a result, it was left to House and Senate leadership to ultimately decide on the amendment’s fate when the two chambers’ appropriations bills were reconciled.
In the past two days as the negotiations reached their peak, over 10,000 members of NORML contacted their federal officials to urge them to maintain these protections.
Additional language was stripped from the Senate version of the bill, known as the Veterans Equal Access amendment. Originally passed last year in the Senate appropriations committee by a vote of 24-7, Republican Congressional leadership thought it prudent to deny American military veterans the ability to participate in state-lawful medical marijuana programs through their VA doctors.
Rep. Earl Blumenauer, namesake on the amendment and the co-chair of the Congressional Cannabis Caucus said “While I’m glad that our medical marijuana protections are included, there is nothing to celebrate since Congress only maintained the status quo. These protections have been law since 2014. This matter should be settled once and for all. Poll after poll shows that the majority of Americans, across every party, strongly favor the right to use medical marijuana.”
He continued, “Instead, Attorney General Jeff Sessions is doubling down on the failed War on Drugs and Republican leadership in Congress—led by Chairman Pete Sessions—is stonewalling. They’re ignoring the will of the American people by blocking protections for state adult-use laws and cannabis banking. They even refused our veterans access to lifesaving medicine.
The fate of this spending bill has yet to be made clear but is deemed a “must pass” piece of legislation as the federal government is set to shut down on March 23rd at midnight if action is not taken.
We will keep you posted as this story develops.
by Justin Strekal, NORML Political Director
March 21, 2018
Comments
Marijuana medicineUpdate: The omnibus passed the House of Representatives on Thursday.
As part of the newly proposed appropriations package known as an omnibus bill, a spending restriction upon the Department of Justice from prosecuting state-legal medical marijuana programs will remain in place through the end of September.
Known as the Rohrabacher-Blumenauer amendment, it explicitly states that federal funds cannot be used to prevent states from “implementing their own state laws that authorize the use, distribution, possession or cultivation of medical marijuana.”
The amendment has been in place since 2014, as part of annual spending bills. Because the provision was initially approved as a budgetary amendment, it must be explicitly re-authorized by Congress as part of either a continuing resolution or a new fiscal year appropriations bill in order to maintain in effect.
Attorney General Jeff Sessions wants nothing more than to see these protections go away. In a letter he sent to Congressional leadership last year, he wrote: “I believe it would be unwise for Congress to restrict the discretion of the Department to fund particular prosecutions, particularly in the midst of a historic drug epidemic and potentially long-term uptick in violent crime.”
In the past month, NORML has worked with Representatives Rohrabacher and Blumenauer in recruiting 60 additional members of Congress to co-sign a letter of their own to Congressional leadership, which states, “We respectfully request that you include language barring the Department of Justice from prosecuting those who comply with their state’s medical marijuana laws. We believe such a policy is not only consistent with the wishes of a bipartisan majority of the members of the House, but also with the wishes of the American people.”
Last year, the language was initially included as part of a Senate appropriations bill thanks to Senator Patrick Leahy (D-VT) yet was absent from the House’s funding proposal because House Rules Committee Chair Peter Sessions (R-TX) refused to allow House members to vote on it. As a result, it was left to House and Senate leadership to ultimately decide on the amendment’s fate when the two chambers’ appropriations bills were reconciled.
In the past two days as the negotiations reached their peak, over 10,000 members of NORML contacted their federal officials to urge them to maintain these protections.
Additional language was stripped from the Senate version of the bill, known as the Veterans Equal Access amendment. Originally passed last year in the Senate appropriations committee by a vote of 24-7, Republican Congressional leadership thought it prudent to deny American military veterans the ability to participate in state-lawful medical marijuana programs through their VA doctors.
Rep. Earl Blumenauer, namesake on the amendment and the co-chair of the Congressional Cannabis Caucus said “While I’m glad that our medical marijuana protections are included, there is nothing to celebrate since Congress only maintained the status quo. These protections have been law since 2014. This matter should be settled once and for all. Poll after poll shows that the majority of Americans, across every party, strongly favor the right to use medical marijuana.”
He continued, “Instead, Attorney General Jeff Sessions is doubling down on the failed War on Drugs and Republican leadership in Congress—led by Chairman Pete Sessions—is stonewalling. They’re ignoring the will of the American people by blocking protections for state adult-use laws and cannabis banking. They even refused our veterans access to lifesaving medicine.
The fate of this spending bill has yet to be made clear but is deemed a “must pass” piece of legislation as the federal government is set to shut down on March 23rd at midnight if action is not taken.
We will keep you posted as this story develops.
(1)
(0)Rising India Inc (RBII) Stock Research Links
Louis Pasteur -- chance favours only the prepared mind.
Lecture, University of Lille (7 December 1854)
Lecture, University of Lille (7 December 1854)